Who are serum antiscorpion's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Anti-scorpion venom serum Birmex.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/serum-antiscorpion.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

serum antiscorpion — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

serum antiscorpion (serum antiscorpion) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antivenom (polyclonal antiserum). Area: Toxicology / Emergency Medicine.

marketed Antivenom (polyclonal antiserum) Scorpion venom toxins (multiple epitopes) Toxicology / Emergency Medicine Biologic Live · refreshed every 30 min

Target snapshot

serum antiscorpion (serum antiscorpion) — Laboratorios de Biologicos y Reactivos de México, S.A. de C.V.. Serum antiscorpion is a polyclonal antivenom that neutralizes scorpion venom toxins through specific antibody binding.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
serum antiscorpion TARGET	serum antiscorpion	Laboratorios de Biologicos y Reactivos de México, S.A. de C.V.	marketed	Antivenom (polyclonal antiserum)	Scorpion venom toxins (multiple epitopes)
Anti-scorpion venom serum Birmex	Anti-scorpion venom serum Birmex	Laboratorios de Biologicos y Reactivos de México, S.A. de C.V.	phase 3	Antivenom (polyclonal antiserum)	Scorpion venom toxins (multiple components including neurotoxins)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antivenom (polyclonal antiserum) class)

Laboratorios de Biologicos y Reactivos de México, S.A. de C.V. · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). serum antiscorpion — Competitive Intelligence Brief. https://druglandscape.com/ci/serum-antiscorpion. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing